QUATTRO-II randomized trial: CAPOXIRI+bevacizumab vs. FOLFOXIRI+bevacizumab as first-line treatment in patients with mCRC
| Autor: | Bando, Hideaki, Kotani, Daisuke, Satake, Hironaga, Hamaguchi, Tetsuya, Shiozawa, Manabu, Kotaka, Masahito, Masuishi, Toshiki, Yasui, Hisateru, Kagawa, Yoshinori, Komatsu, Yoshito, Oki, Eiji, Yamamoto, Yoshiyuki, Kawakami, Hisato, Misumi, Toshihiro, Taniguchi, Hiroya, Yamazaki, Kentaro, Muro, Kei, Yoshino, Takayuki, Kato, Takeshi, Tsuji, Akihito |
|---|---|
| Zdroj: | In Med 13 September 2024 5(9):1164-1177 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|